PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2020331
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2020331
Allergy Immunotherapy Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of allergy immunotherapy Market
The global allergy immunotherapy market was valued at USD 1.99 billion in 2025 and is projected to grow to USD 2.17 billion in 2026, reaching USD 5.14 billion by 2034, exhibiting a robust CAGR of 11.38% during 2026-2034. The market growth is primarily driven by the increasing prevalence of allergic diseases such as allergic rhinitis, asthma, and food allergies, along with rising awareness regarding long-term treatment solutions.
Allergy immunotherapy, also known as allergen desensitization, involves repeated administration of allergens to reduce immune sensitivity. This therapy helps in preventing severe allergic reactions caused by triggers such as pollen, dust mites, and insect stings.
Key Market Insights
Europe dominated the global market in 2025, accounting for 71.08% share, supported by strong reimbursement policies, high allergy prevalence, and significant research investments. Subcutaneous immunotherapy (SCIT) held the largest share due to its proven efficacy, while sublingual immunotherapy (SLIT) is expected to witness the fastest growth due to ease of administration and improved patient compliance.
Countries such as Japan, the U.S., and China are emerging as key contributors due to increasing awareness, regulatory advancements, and expanding product pipelines.
Market Trends
A major trend shaping the market is the shift toward sublingual immunotherapy (SLIT) tablets and drops. Compared to traditional allergy shots (SCIT), SLIT offers advantages such as convenience, reduced risk of systemic reactions, and at-home administration.
Pharmaceutical companies are increasingly investing in SLIT product development to meet growing demand. The rising physician preference for prescribing SLIT therapies further supports this trend, especially for patients with single-allergen sensitivities.
Market Drivers
The increasing global prevalence of allergies is a key factor driving market growth. Studies indicate that allergic rhinitis affects nearly 25%-40% of the global population. Environmental changes, pollution, and lifestyle factors have significantly increased exposure to allergens.
Additionally, growing government initiatives, funding support, and awareness campaigns are encouraging early diagnosis and treatment. Strategic collaborations between biotech firms and pharmaceutical companies are also accelerating innovation and expanding treatment options.
Market Restraints
Despite strong growth potential, the market faces challenges such as high treatment costs and low patient adherence. Immunotherapy requires long-term commitment, which discourages many patients from completing treatment cycles.
Limited insurance coverage, especially for newer therapies like SLIT drops in certain countries, further restricts accessibility. Adverse effects and inconvenience associated with frequent clinic visits for SCIT also impact adoption rates.
Segmentation Analysis
By Type
- SCIT (Subcutaneous Immunotherapy): Dominated the market in 2026 with high efficacy and long-standing clinical acceptance.
- SLIT (Sublingual Immunotherapy): Expected to grow rapidly due to convenience, safety, and increasing product approvals.
By Application
- Allergic Rhinitis: Largest segment with 68.83% share in 2026, driven by high disease prevalence.
- Allergic Asthma & Others: Expected to grow steadily due to rising R&D investments and expanding treatment indications.
By Distribution Channel
- Retail & Online Pharmacies: Dominated with 86.75% share in 2026 due to accessibility and convenience.
- Hospital Pharmacies: Witnessing steady growth supported by increasing hospital admissions.
Regional Analysis
- Europe: Largest market with USD 1.42 billion in 2025, driven by strong healthcare infrastructure and reimbursement policies.
- Asia Pacific: Fastest-growing region due to rising awareness and increasing allergy burden.
- North America: Significant growth supported by high diagnosis rates and advanced treatment adoption.
- Latin America & Middle East & Africa: Gradual growth due to improving healthcare systems and government initiatives.
Competitive Landscape
The market is semi-consolidated with key players such as ALK, Stallergenes Greer, Allergy Therapeutics, and Dermapharm. These companies focus on strategic partnerships, R&D investments, and product innovation to strengthen their market presence.
Conclusion
The global allergy immunotherapy market is set for strong growth from USD 1.99 billion in 2025 to USD 5.14 billion by 2034, driven by rising allergy prevalence, increasing awareness, and advancements in treatment options. While challenges such as high costs and low adherence persist, the growing adoption of convenient therapies like SLIT and continuous innovation by key players are expected to transform the treatment landscape. Overall, the market presents significant opportunities, particularly in emerging regions, as healthcare access and patient awareness continue to improve.
Segmentation By Type
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
By Application
- Allergic Rhinitis
- Allergic Asthma
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies & Online Pharmacies
By Geography
- North America (By Type, By Application, By Distribution Channel, By Country)
- U.S.
- Canada
- Europe (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
- Germany
- France
- U.K.
- Italy
- Spain
- Netherlands
- Belgium
- Poland
- Sweden
- Norway
- Denmark
- Rest of Europe
- Asia Pacific (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
- China
- India
- Japan
- Australia
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Conditions (Food Allergy, Allergic Rhinitis, etc.), By Key Countries/Regions, 2025/ 2026
- 4.2. Pipeline Analysis, By Key Players
- 4.3. Key Industry Developments- Merger, Acquisitions, and Partnerships
- 4.4. New Product Launches, By Key Players
- 4.5. Impact of COVID-19 on the Market
5. Global Allergy Immunotherapy Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Type
- 5.1.1. Subcutaneous Immunotherapy
- 5.1.2. Sublingual Immunotherapy
- 5.2. Market Analysis, Insights and Forecast - By Application
- 5.2.1. Allergic Rhinitis
- 5.2.2. Allergic Asthma
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 5.3.1. Hospital Pharmacies
- 5.3.2. Retail and Online Pharmacies
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Allergy Immunotherapy Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Type
- 6.1.1. Subcutaneous Immunotherapy
- 6.1.2. Sublingual Immunotherapy
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1. Allergic Rhinitis
- 6.2.2. Allergic Asthma
- 6.2.3. Others
- 6.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 6.3.1. Hospital Pharmacies
- 6.3.2. Retail and Online Pharmacies
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Allergy Immunotherapy Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Type
- 7.1.1. Subcutaneous Immunotherapy
- 7.1.2. Sublingual Immunotherapy
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1. Allergic Rhinitis
- 7.2.2. Allergic Asthma
- 7.2.3. Others
- 7.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 7.3.1. Hospital Pharmacies
- 7.3.2. Retail and Online Pharmacies
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.4.1. Germany
- 7.4.2. France
- 7.4.3. U.K.
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Netherlands
- 7.4.7. Belgium
- 7.4.8. Poland
- 7.4.9. Sweden
- 7.4.10. Norway
- 7.4.11. Denmark
- 7.4.12. Rest of Europe
8. Asia Pacific Allergy Immunotherapy Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Type
- 8.1.1. Subcutaneous Immunotherapy
- 8.1.2. Sublingual Immunotherapy
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1. Allergic Rhinitis
- 8.2.2. Allergic Asthma
- 8.2.3. Others
- 8.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 8.3.1. Hospital Pharmacies
- 8.3.2. Retail and Online Pharmacies
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Australia
- 8.4.4. Japan
- 8.4.5. South Korea
- 8.4.6. Southeast Asia
- 8.4.7. Rest of Asia Pacific
9. Latin America Allergy Immunotherapy Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Type
- 9.1.1. Subcutaneous Immunotherapy
- 9.1.2. Sublingual Immunotherapy
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1. Allergic Rhinitis
- 9.2.2. Allergic Asthma
- 9.2.3. Others
- 9.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 9.3.1. Hospital Pharmacies
- 9.3.2. Retail and Online Pharmacies
- 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Colombia
- 9.4.4. Rest of Latin America
10. Middle East & Africa Allergy Immunotherapy Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Type
- 10.1.1. Subcutaneous Immunotherapy
- 10.1.2. Sublingual Immunotherapy
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1. Allergic Rhinitis
- 10.2.2. Allergic Asthma
- 10.2.3. Others
- 10.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 10.3.1. Hospital Pharmacies
- 10.3.2. Retail and Online Pharmacies
- 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. ALK
- 11.2.1.1. Product
- 11.2.1.2. Overview
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. financials (Based on Availability)
- 11.2.2. Stallergenes Greer
- 11.2.2.1. Product
- 11.2.2.2. Overview
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. financials (Based on Availability)
- 11.2.3. Allergy Therapeutics
- 11.2.3.1. Product
- 11.2.3.2. Overview
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. financials (Based on Availability)
- 11.2.4. HAL Allergy B.V.
- 11.2.4.1. Product
- 11.2.4.2. Overview
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. financials (Based on Availability)
- 11.2.5. HollisterStier Allergy
- 11.2.5.1. Product
- 11.2.5.2. Overview
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. financials (Based on Availability)
- 11.2.6. Zhejiang Wolwo Bio-pharmaceutical Co.,Ltd
- 11.2.6.1. Product
- 11.2.6.2. Overview
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. financials (Based on Availability)
- 11.2.7. LETIPharma
- 11.2.7.1. Product
- 11.2.7.2. Overview
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. financials (Based on Availability)
- 11.2.8. Dermapharm Holding SE
- 11.2.8.1. Product
- 11.2.8.2. Overview
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. financials (Based on Availability)
- 11.2.1. ALK
List of Tables
- Table 01: Global Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 02: Global Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 03: Global Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034
- Table 04: Global Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Region, 2021-2034
- Table 05: North America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 06: North America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 07: North America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034
- Table 08: North America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 09: Europe Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 10: Europe Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 11: Europe Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034
- Table 12: Europe Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
- Table 13: Asia Pacific Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 14: Asia Pacific Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 15: Asia Pacific Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034
- Table 16: Asia Pacific Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
- Table 17: Latin America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 18: Latin America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 19: Latin America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034
- Table 20: Latin America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
- Table 21: Middle East & Africa Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 22: Middle East & Africa Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 23: Middle East & Africa Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034
- Table 24: Middle East & Africa Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
List of Figures
- Figure 01: Global Allergy Immunotherapy Market Revenue Breakdown (USD billion, %) by Region, 2026 & 2034
- Figure 02: Global Allergy Immunotherapy Market Value Share (%), By Type, 2026 & 2034
- Figure 03: Global Allergy Immunotherapy Market Value Share (%), By Application, 2026 & 2034
- Figure 04: Global Allergy Immunotherapy Market Value Share (%), By Distribution Channel, 2026 & 2034
- Figure 05: Global Allergy Immunotherapy Market Value (USD billion), By Region, 2026 & 2034
- Figure 06: North America Allergy Immunotherapy Market Value (USD billion), by Type, 2026 & 2034
- Figure 07: North America Allergy Immunotherapy Market Value Share (%), by Type, 2025
- Figure 08: North America Allergy Immunotherapy Market Value (USD billion), by Application, 2026 & 2034
- Figure 09: North America Allergy Immunotherapy Market Value Share (%), by Application, 2025
- Figure 10: North America Allergy Immunotherapy Market Value (USD billion), by Distribution Channel, 2026 & 2034
- Figure 11: North America Allergy Immunotherapy Market Value Share (%), by Distribution Channel, 2025
- Figure 12: North America Allergy Immunotherapy Market Value (USD billion), by Country, 2026 & 2034
- Figure 13: North America Allergy Immunotherapy Market Value Share (%), by Country, 2025
- Figure 14: Europe Allergy Immunotherapy Market Value (USD billion), by Type, 2026 & 2034
- Figure 15: Europe Allergy Immunotherapy Market Value Share (%), by Type, 2025
- Figure 16: Europe Allergy Immunotherapy Market Value (USD billion), by Application, 2026 & 2034
- Figure 17: Europe Allergy Immunotherapy Market Value Share (%), by Application, 2025
- Figure 18: Europe Allergy Immunotherapy Market Value (USD billion), by Distribution Channel, 2026 & 2034
- Figure 19: Europe Allergy Immunotherapy Market Value Share (%), by Distribution Channel, 2025
- Figure 20: Europe Allergy Immunotherapy Market Value (USD billion), by Country/ Sub-region, 2026 & 2034
- Figure 21: Europe Allergy Immunotherapy Market Value Share (%), by Country/ Sub-region, 2025
- Figure 22: Asia Pacific Allergy Immunotherapy Market Value (USD billion), by Type, 2026 & 2034
- Figure 23: Asia Pacific Allergy Immunotherapy Market Value Share (%), by Type, 2025
- Figure 24: Asia Pacific Allergy Immunotherapy Market Value (USD billion), by Application, 2026 & 2034
- Figure 25: Asia Pacific Allergy Immunotherapy Market Value Share (%), by Application, 2025
- Figure 26: Asia Pacific Allergy Immunotherapy Market Value (USD billion), by Distribution Channel, 2026 & 2034
- Figure 27: Asia Pacific Allergy Immunotherapy Market Value Share (%), by Distribution Channel, 2025
- Figure 28: Asia Pacific Allergy Immunotherapy Market Value (USD billion), by Country/Sub-region, 2026 & 2034
- Figure 29: Asia Pacific Allergy Immunotherapy Market Value Share (%), by Country/Sub-region, 2025
- Figure 30: Latin America Allergy Immunotherapy Market Value (USD billion), by Type, 2026 & 2034
- Figure 31: Latin America Allergy Immunotherapy Market Value Share (%), by Type, 2025
- Figure 32: Latin America Allergy Immunotherapy Market Value (USD billion), by Application, 2026 & 2034
- Figure 33: Latin America Allergy Immunotherapy Market Value Share (%), by Application, 2025
- Figure 34: Latin America Allergy Immunotherapy Market Value (USD billion), by Distribution Channel, 2026 & 2034
- Figure 35: Latin America Allergy Immunotherapy Market Value Share (%), by Distribution Channel, 2025
- Figure 36: Latin America Allergy Immunotherapy Market Value (USD billion), by Country/Sub-region, 2026 & 2034
- Figure 37: Latin America Allergy Immunotherapy Market Value Share (%), by Country/Sub-region, 2025
- Figure 38: Middle East & Africa Allergy Immunotherapy Market Value (USD billion), by Type, 2026 & 2034
- Figure 39: Middle East & Africa Allergy Immunotherapy Market Value Share (%), by Type, 2025
- Figure 40: Middle East & Africa Allergy Immunotherapy Market Value (USD billion), by Application, 2026 & 2034
- Figure 41: Middle East & Africa Allergy Immunotherapy Market Value Share (%), by Application, 2025
- Figure 42: Middle East & Africa Allergy Immunotherapy Market Value (USD billion), by Distribution Channel, 2026 & 2034
- Figure 43: Middle East & Africa Allergy Immunotherapy Market Value Share (%), by Distribution Channel, 2025
- Figure 44: Middle East & Africa Allergy Immunotherapy Market Value (USD billion), by Country/Sub-region, 2026 & 2034
- Figure 45: Middle East & Africa Allergy Immunotherapy Market Value Share (%), by Country/Sub-region, 2025
- Figure 46: Global Allergy Immunotherapy Market Share (%), By Company, 2025
